- Home
- ZJYL vs IGC Comparison
ZJYL vs IGC Comparison
Compare ZJYL & IGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ZJYL | IGC |
|---|---|---|
| Founded | 2006 | 2005 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Industrial Specialties | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 32.7M | 28.5M |
| IPO Year | 2023 | N/A |
Fundamental Metrics
Financial Performance| Metric | ZJYL | IGC |
|---|---|---|
| Price | $0.16 | $0.28 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $4.13 |
| AVG Volume (30 Days) | ★ 1.3M | 455.0K |
| Earning Date | 08-20-2025 | 02-17-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.01 | N/A |
| Revenue | ★ $22,826,624.00 | $1,106,000.00 |
| Revenue This Year | N/A | $3.54 |
| Revenue Next Year | N/A | $15.12 |
| P/E Ratio | $13.19 | ★ N/A |
| Revenue Growth | ★ 13.42 | N/A |
| 52 Week Low | $0.11 | $0.25 |
| 52 Week High | $1.03 | $0.50 |
Technical Indicators
Market Signals| Indicator | ZJYL | IGC |
|---|---|---|
| Relative Strength Index (RSI) | 39.35 | 41.97 |
| Support Level | $0.12 | $0.29 |
| Resistance Level | $0.18 | $0.31 |
| Average True Range (ATR) | 0.03 | 0.01 |
| MACD | -0.00 | 0.00 |
| Stochastic Oscillator | 30.12 | 13.14 |
Price Performance
Historical ComparisonAbout ZJYL JIN MEDICAL INTERNATIONAL LTD.
Jin Medical International Ltd offers rehabilitation equipment. It is engaged in the design, development, manufacturing, and sales of wheelchairs and other living aids products to be used by people with disabilities or impaired mobility. The company's products are sold to distributors in both China and overseas markets. Its product offerings comprise Wheelechaire serirs, Bath products, oxygen machines, and nursing products. Geographically, it generates the majority of its revenue from Japan.
About IGC IGC Pharma Inc.
IGC Pharma Inc develops cannabinoid-based formulations for treating diseases and conditions, including, but not limited to, Alzheimer's disease, period cramps, premenstrual syndrome, and chronic pain. The company has investigational drug assets targeting Alzheimer's disease, IGC-AD1, IGC-M3, IGC-1C, and TGR-63, which have demonstrated in Alzheimer's cell lines the potential to be effective in suppressing or ameliorating key hallmarks of Alzheimer's disease, such as plaques or tangles.